HDAC9 and cancer: By comparison, the known HDAC inhibitor vorinostat displayed an IC50 value of 57 nM against HeLa nuclear extract-derived HDAC activity and IC50 values of 0.36 and 1.49 μM against MV4-11 and PC-3 cancer cell lines, respectively.